TELA Bio, Inc.
TELA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001561921
In the last 90 days, TELA Bio, Inc. insiders filed 4 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $19.3M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in TELA Bio, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −6 vs. Q4 2021
- Shares held
- 11.2M
- +629.3K (+6.0%) vs. Q4 2021
- Total value
- $129.8M
- −$5.01M (−3.7%) vs. Q4 2021
- New holders
- 2
- 11 more added
- Sold out
- 8
- 9 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TELA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $19.3M |
| Q1 2026 | 36 | $16.7M |
| Q4 2025 | 42 | $32.5M |
| Q3 2025 | 40 | $35.1M |
| Q2 2025 | 46 | $45.5M |
| Q1 2025 | 50 | $30.0M |
| Q4 2024 | 47 | $81.6M |
| Q3 2024 | 49 | $45.6M |
| Q2 2024 | 68 | $93.4M |
| Q1 2024 | 59 | $120.6M |
| Q4 2023 | 61 | $142.7M |
| Q3 2023 | 68 | $178.1M |
| Q2 2023 | 68 | $227.2M |
| Q1 2023 | 54 | $180.2M |
| Q4 2022 | 49 | $200.4M |
| Q3 2022 | 45 | $143.0M |
| Q2 2022 | 32 | $95.0M |
| Q1 2022 | 30 | $129.8M |
| Q4 2021 | 36 | $134.8M |
| Q3 2021 | 38 | $139.8M |
| Q2 2021 | 45 | $164.9M |
| Q1 2021 | 47 | $147.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding TELA Bio, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 43 | $1.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 206 | $2.00K | 0.00% | +171+488.6% | Added |
| Citigroup Inc | 171 | $2.00K | 0.00% | +171 | New |
| Royal Bank of Canada | 1,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,132 | $13.0K | 0.00% | −11,717−91.2% | Reduced |
| Tower Research Capital LLC (TRC) | 1,190 | $14.0K | 0.00% | +677+132.0% | Added |
| Two Sigma Investments, LP | 10,548 | $123.0K | 0.00% | −5,500−34.3% | Reduced |
| Northern Trust Corp | 14,912 | $173.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 16,380 | $190.0K | 0.00% | −3,471−17.5% | Reduced |
| BlackRock Inc. | 21,423 | $249.0K | 0.00% | −969−4.3% | Reduced |
| State Street Corp | 26,065 | $303.0K | 0.00% | +2,167+9.1% | Added |
| WMS Partners, LLC | 28,150 | $327.0K | 0.04% | +28,150 | New |
| The PNC Financial Services Group, Inc. | 47,179 | $549.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 62,000 | $721.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 64,922 | $755.0K | 0.00% | −10.0% | Reduced |
| Sanders Morris Harris LLC | 105,168 | $1.22M | 0.24% | −2,000−1.9% | Reduced |
| Parkman Healthcare Partners LLC | 108,504 | $1.26M | 0.37% | +4,222+4.0% | Added |
| Jacob Asset Management of New York LLC | 128,994 | $1.50M | 0.91% | −4,006−3.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 145,736 | $1.69M | 0.02% | +1,600+1.1% | Added |
| Armistice Capital, LLC | 192,000 | $2.23M | 0.06% | −156,000−44.8% | Reduced |
| Granite Point Capital Management, L.P. | 227,644 | $2.65M | 1.34% | 00.0% | Unchanged |
| Pentwater Capital Management LP | 312,238 | $3.63M | 0.07% | 00.0% | Unchanged |
| Vanguard Group Inc | 391,568 | $4.55M | 0.00% | +43,633+12.5% | Added |
| Silvercrest Asset Management Group LLC | 396,585 | $4.61M | 0.03% | +3,610+0.9% | Added |
| Velan Capital Investment Management LP | 451,400 | $5.25M | 4.87% | +151,400+50.5% | Added |
| Opaleye Management Inc. | 477,000 | $5.55M | 1.72% | +27,133+6.0% | Added |
| Pura Vida Investments, LLC | 567,420 | $6.60M | 0.80% | +3,300+0.6% | Added |
| RTW Investments, LP | 1,017,546 | $11.8M | 0.24% | −382,140−27.3% | Reduced |
| OrbiMed Advisors LLC | 3,027,542 | $35.2M | 0.57% | 00.0% | Unchanged |
| Essex Woodlands Management, Inc. | 3,316,236 | $38.6M | 9.32% | +1,410,008+74.0% | Added |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −434,033−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −19,662−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,900−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,521−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −4,035−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −413−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −356−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |